Description: Futura Medical plc, a pharmaceutical company, researches and develops pharmaceutical drugs and medical devices for the consumer healthcare markets focusing on sexual healthcare and pain relief management. The company offers CSD500, a condom that contains erectogenic gel. It is also developing MED2005, a topical gel applied directly to the head of penis for the treatment of male erectile dysfunction that is in Phase III clinical trials. In addition, the company develops pain relief products, including TPR100, a topical diclofenac pain relief gel; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Home Page: www.futuramedical.com
Surrey Technology Centre
Guildford,
GU2 7YG
United Kingdom
Phone:
44 14 8368 5670
Officers
| Name | Title |
|---|---|
| Mr. James Henry Barder | CEO & Exec. Director |
| Ms. Angela Hildreth | COO, Fin. Director, Company Sec. & Exec. Director |
| Mr. Kenneth William James | Head of R&D & Exec. Director |
| Dr. William Duncan Potter | Chief Scientific Officer & Adviser to the Board |
| Graham Smith | Head of Alliance Partnerships & Supply |
| Kevin Langridge | Head of Quality |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 17.5949 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 11 |